Currently funded projects
Identification and validation of stroke etiology defining discriminative factors with diagnostic implications in thrombus immune cells
Institution: Medizinische Klinik und Poliklinik I, LMU Klinikum
Applicant: Dr. Kami Alexander Pekayvaz
EKFS funding line: First and Second Applications
Deciphering epigenetic mechanisms underlying disease persistence under Menin-inhibitor treatment in Acute Myeloid Leukemia
Institution: Klinik für Innere Medizin C, Universitätsmedizin Greifswald
Applicant: Dr. Florian Perner
EKFS funding line: First and Second Applications
Prospective quality assurance study for the application of Cytosorb® in patients with cytokine storm, rhabdomyolysis and acute liver failure (= Cyto-SOLVE)
Institution: Klinik für Anästhesiologie, LMU Klinikum
Applicant: Dr. Christina Scharf
EKFS funding line: First and Second Applications
Novel therapeutic directions to reduce thrombotic risk in patients with chronic kidney disease by targeting a pathological endothelium-platelet crosstalk
Institution: Institute for Molecular Cardiovascular Research (IMCAR), RWTH Aachen University, University Hospital Aachen
Applicant: Heidi Noels
EKFS funding line: First and Second Applications
Non-invasive monitoring of minimal residual disease and Graft-versus-Host-Disease by circulating nucleic acids after allogeneic hematopoietic transplantation
Institution: Department of Internal Medicine I (Hematology/Oncology/Stem Cell Transplantation), University of Freiburg Medical Center
Applicant: Jesús Duque-Afonso, MD
EKFS funding line: First and Second Applications
Klonale Hämatopoese: klinische Auswirkungen und funktionelle Konsequenzen im Stammzell-Kompartiment
Institution: Charité – Universitätsmedizin Berlin
Applicant: Frederik Damm
EKFS funding line: Else Kröner Excellence Fellowship
Deciphering the oncogenic epitranscriptome in acute lymphoblastic T-cell leukemia using functional genetics
Institution: Department of Hematology/ Oncology and Institute of Experimental Hematology, Hannover Medical School
Applicant: Dr. Dr. Adrian Schwarzer
EKFS funding line: First and Second Applications
New approaches towards an effective antibody-based intervention against infections with the human cytomegalovirus (HCMV)
Institutions: University Hospital Ulm and University Hospital Essen
Applicants: Christian Sinzger, Adalbert Krawczyk and Ramin Lotfi
EKFS funding line: key project
Functional clustering of T cell and other immune cell sub-phenotypes across plasticity and individualities of immune-mediated diseases.
Institution: Institute for Medical Microbiology and Hygiene, Philipps-Universität Marburg
Applicant: Prof. Dr. Michael Lohoff
EKFS funding line: First and Second Applications
Characterization of platelet bone morphogenetic protein (BMP)-4 in atherothrombosis
Institution: Department of Cardiology and Angiology I, Heart Center Freiburg University, Faculty of Medicine, University of Freiburg, Germany
Applicant: PD Dr. Qian Zhou
EKFS funding line: First and Second Applications